Chief of High Authority for Medicines, Relief International discuss strengthening cooperation

Yemen Condemns Targeting Site at Khartoum Airport, Affirms Support for Sudan

The Republic of Yemen has expressed its strong condemnation and denunciation of targeting a site inside Khartoum Airport in the sisterly Republic of Sudan.

Arab League Calls for Confronting Rising Anti-Muslim Hate

The Arab League on Sunday called for intensified international efforts to confront the growing phenomenon of hate speech and discrimination against Muslims in order to prevent deeper divisions among religions and cultures.

Oil price tops $100 a barrel

Oil prices jumped above $100 per barrel today, Monday, as the U.S. Navy prepares to take control of ship movements in the Strait of Hormuz.

Inter Milan a win away from Serie A title

Inter Milan continued its successful march to reclaim the Italian football league title, despite drawing with its host Torino (2-2), in the conclusion of the 34th round of the competition.

Last Update: ، 2026/05/06 Time 01:27:34
Latest News:

Minister of Oil Discusses Investment Prospects with German Ambassador

Yemen’s Ambassador Discusses Bilateral Ties with German Official

Health Minister Hails Landmark Liver Transplants in Taiz

MASAM Clears Minefield Near Populated Area in Midi, Hodeidah

Yemen’s Social Affairs Minister Discusses Social Protection Cooperation with Swiss Ambassador

Chief of High Authority for Medicines, Relief International discuss strengthening cooperation

[10/12/2024 01:24]

ADEN - SABA
The Executive Director-General of the High Authority for Medicines and Medical Supplies Dr. Abdelkadir al-Bakri held talks with a team from Relief International here today over several of issues of relevance to the pharmaceutical sector .

Talks reviewed the procedural and technical steps for the implementation of the project of development and training of local importers of medicines and medical supplies, which is being implemented by the organization in Yemen over a period of two years with funding from the Japanese company Takeda.